Phase II trial of bevacizumab in combination with weekly docetaxel in metastatic breast cancer patients.
Ramaswamy B, Elias AD, Kelbick NT, Dodley A, Morrow M, Hauger M, Allen J, Rhoades C, Kendra K, Chen HX, Eckhardt SG, Shapiro CL.
Ramaswamy B, et al. Among authors: shapiro cl.
Clin Cancer Res. 2006 May 15;12(10):3124-9. doi: 10.1158/1078-0432.CCR-05-2603.
Clin Cancer Res. 2006.
PMID: 16707611
Clinical Trial.